View in EDS

Activator protein-1 (AP-1) inhibition prevents endothelial to mesenchymal transition in diabetes-associated atherosclerosis: a translational study.

Saved in:
Bibliographic Details
Title: Activator protein-1 (AP-1) inhibition prevents endothelial to mesenchymal transition in diabetes-associated atherosclerosis: a translational study.
Authors: Khan AW; Department of diabetes, Central Clinical School of Translational Medicine, Monash University, The Alfred Centre, Level 5, 99 Commercial Road, Melbourne, VIC, 3004, Australia. Waheed.khan@monash.edu.au., Aziz M; Department of diabetes, Central Clinical School of Translational Medicine, Monash University, The Alfred Centre, Level 5, 99 Commercial Road, Melbourne, VIC, 3004, Australia., Sourris KC; Department of diabetes, Central Clinical School of Translational Medicine, Monash University, The Alfred Centre, Level 5, 99 Commercial Road, Melbourne, VIC, 3004, Australia., Cortes JP; Department of diabetes, Central Clinical School of Translational Medicine, Monash University, The Alfred Centre, Level 5, 99 Commercial Road, Melbourne, VIC, 3004, Australia., Block TJ; Department of diabetes, Central Clinical School of Translational Medicine, Monash University, The Alfred Centre, Level 5, 99 Commercial Road, Melbourne, VIC, 3004, Australia., Dai A; Department of diabetes, Central Clinical School of Translational Medicine, Monash University, The Alfred Centre, Level 5, 99 Commercial Road, Melbourne, VIC, 3004, Australia., Maxwell S; Department of diabetes, Central Clinical School of Translational Medicine, Monash University, The Alfred Centre, Level 5, 99 Commercial Road, Melbourne, VIC, 3004, Australia.; Epigenetics in Human Health and Disease Program, Baker Heart and Diabetes Institute, Melbourne, Australia., Okabe J; Department of diabetes, Central Clinical School of Translational Medicine, Monash University, The Alfred Centre, Level 5, 99 Commercial Road, Melbourne, VIC, 3004, Australia.; Epigenetics in Human Health and Disease Program, Baker Heart and Diabetes Institute, Melbourne, Australia., Pyper E; Department of diabetes, Central Clinical School of Translational Medicine, Monash University, The Alfred Centre, Level 5, 99 Commercial Road, Melbourne, VIC, 3004, Australia., Paneni F; Center for Translational and Experimental Cardiology (CTEC), Department of Cardiology, University Hospital Zurich and University of Zürich, Wagistrasse 12, Schlieren, 8952, Switzerland., Cooper ME; Department of diabetes, Central Clinical School of Translational Medicine, Monash University, The Alfred Centre, Level 5, 99 Commercial Road, Melbourne, VIC, 3004, Australia., Jandeleit-Dahm KA; Department of diabetes, Central Clinical School of Translational Medicine, Monash University, The Alfred Centre, Level 5, 99 Commercial Road, Melbourne, VIC, 3004, Australia.; Leibniz Institute for Diabetes Research, Heinrich Heine University, Dusseldorf, Germany.
Source: Cardiovascular diabetology [Cardiovasc Diabetol] 2026 Jan 29; Vol. 25 (1), pp. 61. Date of Electronic Publication: 2026 Jan 29.
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840 (Electronic) Linking ISSN: 14752840 NLM ISO Abbreviation: Cardiovasc Diabetol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41606610
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Activator protein-1 (AP-1) inhibition prevents endothelial to mesenchymal transition in diabetes-associated atherosclerosis: a translational study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Khan+AW%22">Khan AW</searchLink>; Department of diabetes, Central Clinical School of Translational Medicine, Monash University, The Alfred Centre, Level 5, 99 Commercial Road, Melbourne, VIC, 3004, Australia. Waheed.khan@monash.edu.au.<br /><searchLink fieldCode="AU" term="%22Aziz+M%22">Aziz M</searchLink>; Department of diabetes, Central Clinical School of Translational Medicine, Monash University, The Alfred Centre, Level 5, 99 Commercial Road, Melbourne, VIC, 3004, Australia.<br /><searchLink fieldCode="AU" term="%22Sourris+KC%22">Sourris KC</searchLink>; Department of diabetes, Central Clinical School of Translational Medicine, Monash University, The Alfred Centre, Level 5, 99 Commercial Road, Melbourne, VIC, 3004, Australia.<br /><searchLink fieldCode="AU" term="%22Cortes+JP%22">Cortes JP</searchLink>; Department of diabetes, Central Clinical School of Translational Medicine, Monash University, The Alfred Centre, Level 5, 99 Commercial Road, Melbourne, VIC, 3004, Australia.<br /><searchLink fieldCode="AU" term="%22Block+TJ%22">Block TJ</searchLink>; Department of diabetes, Central Clinical School of Translational Medicine, Monash University, The Alfred Centre, Level 5, 99 Commercial Road, Melbourne, VIC, 3004, Australia.<br /><searchLink fieldCode="AU" term="%22Dai+A%22">Dai A</searchLink>; Department of diabetes, Central Clinical School of Translational Medicine, Monash University, The Alfred Centre, Level 5, 99 Commercial Road, Melbourne, VIC, 3004, Australia.<br /><searchLink fieldCode="AU" term="%22Maxwell+S%22">Maxwell S</searchLink>; Department of diabetes, Central Clinical School of Translational Medicine, Monash University, The Alfred Centre, Level 5, 99 Commercial Road, Melbourne, VIC, 3004, Australia.; Epigenetics in Human Health and Disease Program, Baker Heart and Diabetes Institute, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Okabe+J%22">Okabe J</searchLink>; Department of diabetes, Central Clinical School of Translational Medicine, Monash University, The Alfred Centre, Level 5, 99 Commercial Road, Melbourne, VIC, 3004, Australia.; Epigenetics in Human Health and Disease Program, Baker Heart and Diabetes Institute, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Pyper+E%22">Pyper E</searchLink>; Department of diabetes, Central Clinical School of Translational Medicine, Monash University, The Alfred Centre, Level 5, 99 Commercial Road, Melbourne, VIC, 3004, Australia.<br /><searchLink fieldCode="AU" term="%22Paneni+F%22">Paneni F</searchLink>; Center for Translational and Experimental Cardiology (CTEC), Department of Cardiology, University Hospital Zurich and University of Zürich, Wagistrasse 12, Schlieren, 8952, Switzerland.<br /><searchLink fieldCode="AU" term="%22Cooper+ME%22">Cooper ME</searchLink>; Department of diabetes, Central Clinical School of Translational Medicine, Monash University, The Alfred Centre, Level 5, 99 Commercial Road, Melbourne, VIC, 3004, Australia.<br /><searchLink fieldCode="AU" term="%22Jandeleit-Dahm+KA%22">Jandeleit-Dahm KA</searchLink>; Department of diabetes, Central Clinical School of Translational Medicine, Monash University, The Alfred Centre, Level 5, 99 Commercial Road, Melbourne, VIC, 3004, Australia.; Leibniz Institute for Diabetes Research, Heinrich Heine University, Dusseldorf, Germany.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101147637%22">Cardiovascular diabetology</searchLink> [Cardiovasc Diabetol] 2026 Jan 29; Vol. 25 (1), pp. 61. <i>Date of Electronic Publication: </i>2026 Jan 29.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101147637 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1475-2840 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214752840%22">14752840 </searchLink><i>NLM ISO Abbreviation: </i>Cardiovasc Diabetol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41606610
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s12933-025-03060-5
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 61
    Titles:
      – TitleFull: Activator protein-1 (AP-1) inhibition prevents endothelial to mesenchymal transition in diabetes-associated atherosclerosis: a translational study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Khan AW
      – PersonEntity:
          Name:
            NameFull: Aziz M
      – PersonEntity:
          Name:
            NameFull: Sourris KC
      – PersonEntity:
          Name:
            NameFull: Cortes JP
      – PersonEntity:
          Name:
            NameFull: Block TJ
      – PersonEntity:
          Name:
            NameFull: Dai A
      – PersonEntity:
          Name:
            NameFull: Maxwell S
      – PersonEntity:
          Name:
            NameFull: Okabe J
      – PersonEntity:
          Name:
            NameFull: Pyper E
      – PersonEntity:
          Name:
            NameFull: Paneni F
      – PersonEntity:
          Name:
            NameFull: Cooper ME
      – PersonEntity:
          Name:
            NameFull: Jandeleit-Dahm KA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 29
              M: 01
              Text: 2026 Jan 29
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1475-2840
          Numbering:
            – Type: volume
              Value: 25
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Cardiovascular diabetology
              Type: main
ResultId 1